Ireland Judgment

Nikkei / Financial Times [2015] IECompA m15026 (9 June 2015)

On this page

Professional case brief

Research organized from the available case record

Source document

01

Holding and result

The Competition and Consumer Protection Commission determined that the proposed acquisition would not substantially lessen competition in the relevant market and therefore cleared the merger.

Court disposition

merger cleared

Orders

  • The proposed acquisition by Baxter Healthcare Limited of certain assets relating to the medical compounding business of Fannin Limited is cleared.

02

Material facts

Parties

Baxter Healthcare Limited

Acquirer

Fannin Limited

Target

Amounts and remedies

  • Notification Date: 20,150,609
  • Decision Date: 20,151,021

03

Procedural history

  1. Posture

    Merger Clearance / Final Determination

04

Questions and positions

Legal issues

Whether the proposed acquisition would substantially lessen competition in the relevant market

Party arguments

Applicant
Baxter Healthcare Limited argued that the acquisition would not adversely affect competition and would enhance efficiency in the medical compounding business.
Respondent
Fannin Limited did not oppose the merger and asserted that the transaction would not negatively impact competition.

05

Court’s reasoning

  1. 01

    Competition Act 2002 (Ireland)

    Assessment of mergers under Irish competition law to prevent substantial lessening of competition.

06

Ratio, limits and disposition

Ratio decidendi

The Competition and Consumer Protection Commission determined that the proposed acquisition would not substantially lessen competition in the relevant market and therefore cleared the merger.

Court disposition

merger cleared

  • The proposed acquisition by Baxter Healthcare Limited of certain assets relating to the medical compounding business of Fannin Limited is cleared.

Source and reliance status

Official court record

This page organises the available record for research. Confirm quotations, current status, and subsequent treatment against the official source before relying on the case.

Judgment reading view

Judgment text

The complete available source text.

Source document

Court record

Judgment

Judgment

Nikkei / Financial Times [2015] IECompA m15026 (9 June 2015) [ Home ] [ Databases ] [ World Law ] [ Multidatabase Search ] [ Help ] [ Feedback ] [

DONATE ] Irish Competition Authority Decisions You are here:

BAILII >> Databases >> Irish Competition Authority Decisions >> Nikkei / Financial Times [2015] IECompA m15026 (9 June 2015) URL: https://www.bailii.org/ie/cases/IECompA/2015/m15026.html Cite as: [2015] IECompA m15026 [ New search ] [ Help ] Nikkei / Financial Times [2015] IECompA m15026 (9 June 2015) Page Attachment M-15-026 Merger Announcement_3 September 2015.pdf (213.86 KB) (213.86 KB) M-15-026 Baxter Fannin Phase 1 Determination.pdf (135.82 KB) (135.82 KB) Baxter Fannin Determination Announcement 21.10.15.pdf (430.39 KB) (430.39 KB) Transaction details The proposed acquisition by Baxter Healthcare Limited of certain assets relating to the medical compounding business of  Fannin Limited has  been cleared by the Competition and Consumer Protection Commission. Economic sector Media merger Pharmaceutical sector. No Notification date: Tuesday, June 9, 2015 Parties Involved Business activities Baxter Healthcare Limited Baxter Healthcare is a global healthcare company primarily active in the medical device, pharmaceutical and biotechnology sectors. Fannin Limited Fannin is a provider of medical devices, medicines, diagnostic products and related services in Ireland. Case Officer Assigned Contact Details Barry O'Donnell Tel: 01-470 3696, e-mail: barryodonnell@ccpc.ie The deadline for any third parties who wish to make submissions regarding the competition aspects of this

merger is: Phase 1 Phase 2 Monday, June 22, 2015 Monday, September 14, 2015 Date of Requirement for Information Date Information Received Friday, July 17, 2015 Friday, July 24, 2015 Current status Completed Cleared (Phase 2) Decision date: Wednesday, October 21, 2015 Competition and Consumer Protection Commission (Ireland) © BAILII: Copyright Policy | Disclaimers | Privacy Policy | Feedback | Donate to BAILII URL: https://www.bailii.org/ie/cases/IECompA/2015/m15026.html

Source wording is retained. Consult the source document for its original formatting and pagination.

Authorities

Authorities used by the court

Cases, legislation, regulations, and constitutional provisions identified in the available record.

Competition Act 2002 (Ireland)

Legislation

Legislation referenced in the available case record.

Case-aware research

Ask AI about this case

The judgment and available research above are public. New questions open in a separate private conversation grounded in this case.

About this LexChat collection

This page organizes the available case record for research. Verify quotations, current status, and subsequent treatment against the source document. Corrections can be reported to hello@esheria.ai.

Legal information, not legal advice. Research summaries do not replace the judgment.